Amgen Inc (NASDAQ:AMGN) – What You Need to Know About Amgen’s Oncology Line-Up

January 23, 2014 at 06:35 AM EST

[at Motley Fool] – Until recently, Amgen’s oncology presence has been somewhat limited. Over the next several years we can expect the California juggernaut to create big waves with these cancer fighting therapies. . . . → Read More: Amgen Inc (NASDAQ:AMGN) – What You Need to Know About Amgen’s Oncology Line-Up Similar Articles: Eli Lilly and Company (NYSE:LLY) – Lilly issues 2014 forecast in line with Wall St estimates Company Update – Amgen Inc. (NASDAQ:AMGN) – Better Buy: Biogen or Amgen? Pfizer 3rd-qtr profit beats estimates; oncology drugs shine – Pfizer Inc. (NYSE:PFE)

Amgen Inc (NASDAQ:AMGN) [at Motley Fool] – Until recently, Amgen’s oncology presence has been somewhat limited. Over the next several years we can expect the California juggernaut to create big waves with these cancer fighting therapies.
Read more on … [visit site to read more]